These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15801672)

  • 1. Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene.
    Rahman N; Kashif M
    Pharmazie; 2005 Mar; 60(3):197-200. PubMed ID: 15801672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate.
    Moustafa AA
    J Pharm Biomed Anal; 2000 Feb; 22(1):45-58. PubMed ID: 10727122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
    Wahbi AA; Abdel-Razak O; Gazy AA; Mahgoub H; Moneeb MS
    J Pharm Biomed Anal; 2002 Nov; 30(4):1133-42. PubMed ID: 12408904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates.
    Salama F; El-Abasawy N; Abdel Razeq SA; Ismail MM; Fouad MM
    J Pharm Biomed Anal; 2003 Oct; 33(3):411-21. PubMed ID: 14550860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pulse anodic voltammetric determination of pantoprazole in pharmaceutical dosage forms and human plasma using glassy carbon electrode.
    Erk N
    Anal Biochem; 2003 Dec; 323(1):48-53. PubMed ID: 14622958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow-injection biamperometric method for determination of pantoprazole in pharmaceutical tablets.
    Castro SL; Neto OD; Santos SR; Medeiros EP; Lima RA; Martins VL; Araújo MC; Josué CC; Korn M
    J AOAC Int; 2005; 88(4):1064-8. PubMed ID: 16152921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode.
    Radi A
    Farmaco; 2003 Jul; 58(7):535-9. PubMed ID: 12818693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic spectrophotometric method for the determination of norfloxacin in pharmaceutical formulations.
    Rahman N; Ahmad Y; Hejaz Azmi SN
    Eur J Pharm Biopharm; 2004 Mar; 57(2):359-67. PubMed ID: 15018997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets.
    Mohamed GG; Nour El-Dien FA; Khalil SM; El-Tantawy AS
    Drug Test Anal; 2010 Jan; 2(1):28-36. PubMed ID: 20878884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic spectrophotometric determination of certain cephalosporins using oxidized quercetin reagent.
    Saleh GA; El-Shaboury SR; Mohamed FA; Rageh AH
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 73(5):946-54. PubMed ID: 19482508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic spectrophotometric method for the determination of silymarin in pharmaceutical formulations using potassium permanganate as oxidant.
    Rahman N; Khan NA; Azmi SN
    Pharmazie; 2004 Feb; 59(2):112-6. PubMed ID: 15025178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography.
    Koçyiğit-Kaymakçoğlu B; Unsalan S; Rollas S
    Pharmazie; 2006 Jul; 61(7):586-9. PubMed ID: 16889064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.
    Peres O; Oliveira CH; Barrientos-Astigarraga RE; Rezende VM; Mendes GD; de Nucci G
    Arzneimittelforschung; 2004; 54(6):314-9. PubMed ID: 15281616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    El-Sherif ZA; Mohamed AO; El-Bardicy MG; El-Tarras MF
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):814-8. PubMed ID: 16755049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical characterization of pantoprazole sodium hydrates.
    Zupancic V; Ograjsek N; Kotar-Jordan B; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):59-68. PubMed ID: 15707732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized and validated initial-rate method for the determination of perindopril erbumine in tablets.
    Rahman N; Anwar N; Kashif M
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):33-6. PubMed ID: 16394545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities.
    Karljikovic-Rajic K; Novovic D; Marinkovic V; Agbaba D
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1019-27. PubMed ID: 12899989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivariate versus multivariate smart spectrophotometric calibration methods for the simultaneous determination of a quaternary mixture of mosapride, pantoprazole and their degradation products.
    Hegazy MA; Yehia AM; Moustafa AA
    Pharmazie; 2013 May; 68(5):317-26. PubMed ID: 23802428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of pantoprazole and its two metabolites in dog plasma by HPLC.
    Xie Z; Chen X; Jin F; Zhong D
    J Chromatogr Sci; 2005; 43(5):271-5. PubMed ID: 15975247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods.
    Ozaltín N
    J Pharm Biomed Anal; 1999 Jul; 20(3):599-606. PubMed ID: 10701978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.